| GTO ID | GTC1190 |
| Trial ID | NCT00028652 |
| Disease | Metastatic Cancer |
| Altered gene | IL-12 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | IL-12 gene-modified tumor cells |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | Interleukin-12 Gene Therapy in Treating Patients With Skin Metastases |
| Year | 2003 |
| Country | United States |
| Company sponsor | University of Wisconsin, Madison |
| Other ID(s) | CDR0000069115|P30CA014520|WCCC-CO-9771|WCCC-HSC-1998-257|NCI-T98-0025 |
| Cohort 1 | |||||
|
|||||